Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post on X:
“Just started 2025 United States Prostate Cancer Consensus Conference (USPCCC) with Alan H Bryce‘s introductory remarks.
Phil Kuo, City of Hope debating for PSMA PET for treatment selection. Caveat Medical conditions with false positive PSMA PET lesions.”
Later, he shared his post, adding:
“Who’s the best candidate for Lutetium therapy? PSMA PET result matters, but CT/DNA, NGS, and histology also do. Excellent talks by Mike Morris and Oliver Sartor at the 2025 USPCCC, highlighting data by Eugene Kwon and Arun Azad in Nature Medicine.”
More posts featuring Neeraj Agarwal on OncoDaily.
